Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Mu-Opioid Signaling Engagement as a Candidate Maintenance Mechanism for Prolonging Ketamine's Antisuicidal Effects.
Journal: The American journal of psychiatry
Published: June 01, 2026
Major depressive disorder is associated with reduced intrinsic connectivity between the bed nucleus of the stria terminalis and ventral striatum.
Journal: Journal of psychiatry & neuroscience : JPN
Published: May 22, 2026
The Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression: A Phase IIa Proof-of-Concept Clinical Trial.
Journal: Journal of clinical psychopharmacology
Published: February 27, 2026
Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers.
Journal: Research square
Published: February 26, 2026
Time-dependent effects of rapid-acting antidepressants in iPSC-derived neurons from treatment-resistant depression and healthy volunteers.
Journal: Molecular psychiatry
Published: January 29, 2026
Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.
Journal: Molecular psychiatry
Published: October 07, 2025
Blunted arginine vasopressin secretion in individuals experiencing a major depressive episode with comorbid post-traumatic stress disorder: Results from an exploratory study using copeptin as a surrogate marker.
Journal: Journal of neuroendocrinology
Published: September 29, 2025
Thyroid-stimulating hormone is associated with differential antidepressant and anti-anhedonic response to ketamine in bipolar depression but not major depressive disorder.
Journal: Journal of affective disorders
Published: September 24, 2025
Ketamine to enhance methadone treatment retention in patients with opioid use disorder and co-morbid depression.
Journal: The American journal of drug and alcohol abuse
Published: August 22, 2025
Peripheral Microvascular and Cerebral White Matter Dysfunction in Schizophrenia: Implications of a Body-Brain Endothelial Pathophysiology.
Journal: Schizophrenia bulletin
Published: March 04, 2025
Esketamine in depression: putative biomarkers from clinical research.
Journal: European archives of psychiatry and clinical neuroscience
Published: June 04, 2024
Last Updated: 09/26/2026